J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Hisse Senetlerindeki Sıralama
#3891
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Hisse Fiyatı
$26.58
Son senkronizasyon: 2026-07-23
Piyasa Değeri
$4.24B
Değişim (1 gün)
0.00%
Değişim (1 yıl)
38.14%
Ülke
IN
Ticaret J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Kategori
Healthcare
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM) için P/S oranı
October 2026 itibarıyla P/S oranı TTM: 9.35
J. B. Chemicals & Pharmaceuticals Limited şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 9.35'dir. 2024 yılının sonunda şirketin P/S oranı 7.54 idi.
J. B. Chemicals & Pharmaceuticals Limited için P/S oranı geçmişi 2005 - 2026 arası
Her yılın sonunda P/S oranı
| Yıl | P/S Oranı | Değiştir |
|---|---|---|
| 2026 (TTM) | 9.35 | 48.93% |
| 2025 | 6.28 | -16.71% |
| 2024 | 7.54 | 53.78% |
| 2023 | 4.90 | -2.38% |
| 2022 | 5.02 | 3.84% |
| 2021 | 4.84 | 110.26% |
| 2020 | 2.30 | 21.87% |
| 2019 | 1.89 | -0.31% |
| 2018 | 1.89 | -15.47% |
| 2017 | 2.24 | 23.70% |
| 2016 | 1.81 | 12.32% |
| 2015 | 1.61 | 39.47% |
| 2014 | 1.16 | 40.76% |
| 2013 | 0.82 | 27.61% |
| 2012 | 0.64 | -51.50% |
| 2011 | 1.33 | 64.39% |
| 2010 | 0.81 | 88.62% |
| 2009 | 0.43 | -42.68% |
| 2008 | 0.75 | -40.69% |
| 2007 | 1.26 | -36.45% |
| 2006 | 1.98 | 7.09% |
| 2005 | 1.85 | 0.00% |
Benzer şirketler veya rakipler için P/S oranı
| Şirket | P/S Oranı | P/S Oranı Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -24.54% |
IN
|
